Skip to main content

The Wistar Institute

|

Nobel Prize Winner Dr. Carolyn Bertozzi Honored with Wistar’s 2022 Helen Dean King Award

Dr. Carolyn Bertozzi received the 2022 Helen Dean King Award from The Wistar Institute in recognition of her outstanding biomedical research on understanding how sugars that coat our cells impact diseases. “This award is an opportunity to celebrate…
Read more
|

The Lab of the Future: AI’s Impact on Biomedical Research

The evolution of machine learning and artificial intelligence is changing the way the contemporary lab looks and functions. Researchers today are discovering that breakthroughs can happen not only at the bench, but on the desktop. Noam Auslander, Ph…
Read more
|

The Wistar Institute Ranks 3rd in Innovation in New Heartland Forward Report

Think tank Heartland Forward released a new report tracking technology transfers from research institutions that lead to innovations that build stronger economies and The Wistar Institute ranked 3rd in Innovation. The report From Research to Renewal…
Read more
|

The Wistar Institute One of Nation’s Top 3 Research Institutions for Innovation

PHILADELPHIA — (OCTOBER 24, 2022) — The Wistar Institute, a leader in biomedical breakthroughs headquartered in Philadelphia, is one of the nation’s top drivers of innovation, research, and tech transfer toward a stronger economy, according to the r…
Read more
|

Dr. Maureen Murphy: Scientist and Teacher

Wistar offers the perfect blend of qualities for cancer researchers to thrive. Challenging science paired with a social cause is the winning formula that propels Dr. Maureen Murphy in her quest to cure cancer. A researcher for over 25 years, Murphy…
Read more
|

STEM Night at R.W. Brown Boys and Girls Club: Exploring Our Roots with DNA

Dr. Jason Diaz, The Wistar Institute education program director, moved around R.W. Brown Community Center classroom full of aquariums with turtles and fish, assorted plants, and books. Dr. Diaz’s excitement was obvious as he peppered the high school…
Read more
|

Wistar Scientists Identify Link Between Mitochondria and Pancreatic Cancer Risk

PHILADELPHIA — (OCTOBER 12, 2022) — The mitochondria is a key energy-producing component of the human cell that plays an important role in cancer cell metabolism. In a research paper published in PLOS ONE, Dario C. Altieri, M.D., president and chief…
Read more
|

Up in (Antibody) Arms: Synthetic DNA Immunotherapy Platform Combats Brain Cancer

Researchers in the Weiner Lab developed DNA-launched bispecific T cell engagers that controlled tumor growth and improved survival in glioblastoma. Glioblastoma is one of the most severe and aggressive forms of brain cancer with limited treatment op…
Read more
|

Wistar’s Dr. Amelia Escolano Earns NIH Director’s New Innovator Award

PHILADELPHIA — (OCTOBER 4, 2022) — The National Institutes of Health has awarded Amelia Escolano, Ph.D., assistant professor in The Wistar Institute’s Vaccine & Immunotherapy Center, the 2022 NIH Director’s New Innovator Award. The honor provide…
Read more
|

Fighting Breast Cancer Disparities Through Collaboration

A decade-long collaboration between Wistar and ChristianaCare is leading to new discoveries and better treatment for triple-negative breast cancer patients. Dario C. Altieri, M.D., president, CEO, and director of the Ellen and Ronald Caplan Cancer C…
Read more